CSCC NEWS September 2014

CANADIAN SOCIETY OF CL IN ICAL CHEMISTS

LA SOC IÉTÉ CANADIENNE DES CL IN ICO-CHIMISTES

CANADIAN SOCIETY OF CL IN ICAL CHEMISTS

LA SOC IÉTÉ CANADIENNE DES CL IN ICO-CHIMISTES

P.O. Box 1570 Kingston, Ontario, K7L 5C8 Canada 613.531.8899 [email protected]

Vol. 56 No. 5 September 2014 ISSN 0826-1024

The Road to AvonleaNadiad, GJ, India to Saskatoon to Charlottetown, PEI, Canada

The 2014 CSCC International Travel award sponsored by Roche Diagnostics Canada was presented to Dr. Banibrata Mukhopadhyay.

Banibrata and Andrew became acquainted at the Asian Pacific Clinical Chemistry congress in Seoul, Korea in 2010, which lead to several years of correspondence. The grant provided a wonderful

opportunity to further research discussions, exchange clinical practices and to attend the CSCC annual meeting. This visit promised to reveal great differences because Dr. Mukhopadhyay travelled from a land of more than 40°C to the land of less than -40°C.

Dr. Mukhopadhyay was hosted in Saskatoon by the Lyon family. As he recovered from crossing 12 time zones, we walked the Mewassin trail along the South Saskatchewan River and in conservation areas to see the prairie and farm Saskatchewan landscapes. He had a lesson in bottling homemade wine and he showed his musical talents by drumming interesting

Drs. Banibrata Mukhopadhyay and Andrew Lyon outside of St Paul’s Hospital, Saskatoon. We were teased by staff for accidently wearing matching outfits that day.

Indian rhythms while our sons strummed guitars. We worked together over one week. We toured lab facilities, investigated clinical problems with test results with ward staff and participated in department management meetings conducted at visual walls, where performance indicators were discussed. We had a lengthy meeting with a local hemodialysis unit to discuss variability in hemoglobin tests. Dr. Mukhopadhyay works at a renal and transplant hospital and had insight into this clinical problem and we compared the different roles of laboratories to support hemodialysis in India and Canada. Dr. Mukhopadhyay presented a lecture to the Department of Pathology and Laboratory Medicine entitled: Serum Catalytic Iron a Diagnostic & Prognostic Biomarker of Acute Coronary & Kidney Injury and met several local faculty that conduct research on oxidative stress and cardiovascular disease.

We flew to the CSCC meeting in Charlottetown, Prince Edward Island, the land of Avonlea, red soil and potatoes. We participated in the CSCC Charity walk /run and a little sight-seeing in the downtown area. Dr. M joined the CSCC Council dinner and participated in a workshop prior to the meeting. He presented a poster entitled: Hemodialysis induced release in plasma: cell free hemoglobin as a source of catalytic iron in patients on hemodialysis and met a large number of the CSCC members and industry staff at the meeting.

Dr. Mukhopadhyay: “I found an excellent working environment in the health sector and academic fi eld in Canada during my stay at Saskatoon. A disciplined, systematic and planned work fl ow in the clinical laboratory and hospitals gave me an enormous opportunity to learn. The university campus and a visit in the health centres imprinted unforgettable memories in me.

CSCC News • September 20142

The selection of the venue of the CSCC annual meeting was excellent. The waterfront hotel, the highly skilled management of the conference and kind courtesy extended by the executive committee members of the CSCC to me during the conference is really one of the most memorable events in my life. The efforts of Dr. David Kinniburgh and Dr. Andrew Lyon are worthy of special mention for making the conference a great success for me in all aspects.”

By Dr. Andrew Lyon & Dr. Banibrata Mukhopadhyay

The CSCC Charity Walk/Run in Charlottetown – awarded Fastest Walker Award

A discussion group after Dr. Mukhopadhayay’s lecture at the University of Saskatchewan (L. Link, Dr. P Prasad, M. Qureshi, Dr. M Lyon and Dr Mukhopadhyay).

Countdown to MontrealA Little Bit of History

This is the fi rst of a series of articles on the Countdown to Montreal relating to the Annual Joint CSCC-CAP Meeting, June 20-24, 2015 - save the dates plus a bit of extra time

to enjoy all that Montreal and the surrounding area has to offer. The meeting is to be held at the Westin Hotel situated on the border of Old Montreal. We are still in the planning stages but we will have a special Opening Mixer that will take place in Old Montreal with the theme of La Nouvelle France. It is traditional for the fi rst article to give a history of the city where the meeting will be held. However, instead of trying to cram a laundry list of events and dates into a two page article, I have decided to concentrate on the origins of Hochelaga→ Ville-Marie→ Montreal.

I hope that this article will bring to life some of the landmarks as you stroll through Old Montreal.

Ponte à Callière

Ponte à Callière 18th century re-creation.

CSCC News • September 2014 3

In the beginning the area now known as Old Montreal was a low-lying triangle of land fl anked by the St. Lawrence River, a small tributary called the Rivière St-Pierre and by marshy land behind. This was Pointe-à-Callière. The Island of Montreal had been inhabited by idigenous people for some 8000 years. In 1535 Jacques Cartier was the fi rst European to set foot on the island. At that time it was inhabited by the St Lawrence Iroquoians living in a village called Hochelaga. This was a distinct group of people who spoke a language called Laurentian. Cartier’s visit was extremely brief. After distributing presents to the inhabitants-necklaces and trinkets to the women and knives to the men and hiking up the mountain that he named Mont Royal, he and his men left. He wrote down two hundred words of the Laurentian language and left an account of his voyage entitled Relations.

About seventy years after Cartier, explorer Samuel de Champlain went to Hochelaga, but the village no longer existed. Present day historians believe that the St Lawrence Iroquoians were essentially decimated by the Mohawk of the Iroquois. Champlain decided to establish a permanent trading post at Place Royale ( present day Pointe-à-Callière) in order to trade furs with the Algonquins and Hurons with whom he had made an alliance. However this never went past the stage of good intentions and there was only some intermitant trading. So Montreal did not start out as a fur-trading post.

In 1642 lay missionnaries Paul Chomedy de Maisonneuve a 29 year-old military man, Jeanne Mance, a 34 year-old nurse and a few French colonists came to set up a mission named Ville-Marie on the spot later know as Pointe-à-Callière. They sailed under the La Chapelle de Note-Dame-De-Bonsecours


auspicies of a group called the Société des messieurs et dames de Notre-Dame de Montréal founded in 1640 by Jérôme le Royer de la Dauversière, a tax collector and others including Father Jean-Jacques Olier who would go on to found the Sulpicians who later played an important role in education and charity in the colony. The good works of this group were funded by the wealthy nobility and bourgeoisie of France who, caught up in the religious fervour of the Counter-Reformation enthusiastically supported le Royer’s dream of creating a missionary settlement in Montreal. Their goal was to convert the aboriginal population and to establish a Franco-Amerindian society in order to “evangelize” the nomadic tribes. The Société purchased the seigneury of the Island of Montreal.

The Compagnie des cent-associés that owned la Nouvelle France granted the Société de Notre-Dame a great deal of autonomy over its settlement of Montreal. It was able to name its own governor (Maisonneuve) with military and judicial powers and to freely import products that it needed for the colony. The governor of Quebec, Montmagny opposed the settlement deeming it too risky because of the constant attacks by the Iroquois. However, Maisonneuve said that he would build a settlement in Montreal even if “all the trees on the island were to turn into just as many Iroquois”. This, plus the autonomy granted to the new colony irritated the governor and could be the origin of the legendary rivalry between the two future cities.

The founding of Montreal was viewed as a direct threat to the Iroquois who wanted to monopolize the fur trade. Because of these constant threats from the Iroquois, the Montréalistes, as they were callled, lived most of the time in the fort that had been constructed on the site and agriculture that had been another goal of the settlement had not been able to fl ourish. So for a while it was touch and go for the little colony and the population stagnated.

In 1645 a hospital, Hôtel-Dieu, was built and run by Jeanne Mance. It was the fi rst hospital built in North America north of Mexico. Because of the potential for fl ooding, it was not located at Pointe-à-Callière but on the other side of Rivière St-Pierre where the city would later develop. The present-day Hôtel-Dieu Hospital on St Urbain Street can trace its origins to the original and there is a statue of its founder, Jeanne Mance on the property.

In 1651 Maisonneuve returned to France to recruit new settlers. He returned in 1653 with 95 and a further 91 arrived in 1659. This new wave of immigration included couples and single young women who were badly needed to balance the surfi t of men. By 1663 the population had increased to around 600 and by 1731 to 3000. One young woman who was part of this recruitment drive was Marguerite Bourgeoys who wanted to devote herself to educating children. In the early years there were no children to teach due to high infant mortality so she worked alongside the settlers and in 1657 she

Montreal map of Dollier Rue


persuaded a work party to build Ville-Marie’s fi rst permanent church; La Chapelle de Notre-Dame-de-Bonsecours.

Sister Bourgeoys opend her fi rst school in an old barn in 1658. This was the beginning of public schooling in Montreal. Today a commemorative plaque on the wall on the southwest corner of Saint-Dizier and Saint-Paul Streets marks the site of the stable school. The second largest school board in the province of Quebec is named in her honour. She educated the poor, the native population, established a boarding school so that the more affl uant girls would not have to go to Quebec for their education and founded vocational schools for women. She housed the fi lles de roi, (orphans sent to become wives) when they arrived from Europe and screened the male settlers for suitable husbands for the girls. With a handful of companions who followed her to the colony, she founded the Congregation of Notre-Dame de Montréal, one of the fi rst uncloistered communities. She has been declared a saint by the Catholic Church.

One of the objectives of the Société de Notre-Dame was to set up an agricultural settlement. Since the Island of Montreal was a seigneury, Maisonneuve gave parcels of land to settlers prepared to clear them. They were also given cash bonuses. Since this money would have to be returned if they left Montreal, this was an incentive to keep them in the colony once their contracts with the Société de Notre-Dame had ended. On the Island of Montreal rural settlements were divided into strips of long lots or ribbon farms known as côtes (rang in other areas). A côte was a group of fl ats of land and homes arranged one beside the other along the St. Lawrence river or inland along a road of the same name as the côte. The road that leads to each côte was known as a montée. The original names of these subdivisions and roads has been maintained in the toponymy of Montreal like Côte-des-Neiges, Côte-Ste-Catherine, Montée-de-Liesse etc.

Until a new French administration took over from the Compagnie des cent-associés in 1663 and troops were sent in to quell Iroquois attacks, Montreal was subject to frequent raids and development only occurred during intermitant periods of peace. During this time the aboriginal allies were afraid to bring their furs to Montreal and preferred to trade at Quebec or Tadoussac at the mouth of the Sagenuay River even though these places were much further away. Montreal’s involvement in the fur trade began in the 1650’s with a few merchants like Charles Le Moyne and Jacques Le Ber. Because of the Iroquois raids that intensifi ed in the late 1650’s, Frenchmen like Radisson and Des Groseilliers were sent to bring back furs from the Nations around the Great Lakes. Following the French miltary intervention of 1665-66, the fur trade developed rapidly. Aboriginals would bring their pelts to Montreal and the annual fur fair held in the summer was an important event in the commercial life of Montreal. Over time Montreal eliminated these native middlemen and sent their own trading expeditions or coureurs de bois. Expeditions were usually organized by merchants associated with voyageurs who worked the canoes. They would then split the profi ts. As nearby sources of fur-bearing animals were overexploited, the voyageurs had to go further afi eld. So the Montreal fur trade led to exploration of the West and the South. Two examples were Montreal’s Pierre Le Moyne d’Iberville who founded Louisiana and his brother Jean-Baptiste Le Moyne de Bienville who founded

New Orleans. In fact the layout of New Orleans was inspired by the layout of Montreal.

The fact that Montreal had become the organizing force behind the fur trade and the gateway to the West gave the feel to Montreal of a fronteer town compared to the rather staid Quebec City. So even though the institutions and urban planning imparted to Montreal the impression of a typical French town, it was evolving into a truly North American town (while retaining its French soul) where anything was possible.

Dr. Mary-Ann Kallai-Sanfaçon,Co-Chair CSCC-CAP Annual Meeting 2015

References:L’histoire du Vieux Montréal à travers son patrimoine. G. Lauzon et M. Forget, eds,

Les publications du Québec, Ste-Foy, Qc. 2004.Brève histoire de Montréal. P-A Linteau, Les éditions du Boréal, MontréaL, Qc, 2007.This Island in Time. J. Kalbfl eisch.Véhicule Press, Montreal, Qc. 2008.History of Montreal. Wikipedia.Marguerite Bourgeoys. Wikipedia

Statue of Paul Chomedey de Maisonneuve


Introducing the Calgary Biochemistry Fellowship Program

It is my great pleasure to introduce the new Biochemistry Fellowship program that has been recently established in Calgary, Alberta. I would like to start with a little of the history behind the

establishment of a training program in Western Canada. Since 2008 Work had been underway in the province to obtain funding for a Biochemistry Fellowship Program with the anticipated retirements that were looming in the province. A planning committee met in Red Deer in 2007 to lay down the requirements for a training program in Alberta. At the time, it was proposed as a

provincial initiative and a joint proposal was submitted by: Dr. Fiona Bamforth, Dr. George Blakney, Dr. George Cembrowski, Trefor Higgins, Jelena Holovathi, Dr. Annu Khajuria, Dr. Don LeGatt, Dr. Andrew Lyon and Dr. James Wesenberg.

Unfortunately, the proposal was not funded; however, after that, groups at both the University of Alberta and University of Calgary persisted independently in trying to start a program. During his fi rst employment at Calgary Laboratory Services (2009-2010), Dr. Hossein Sadrzadeh submitted a proposal to the Department of Pathology and Laboratory Medicine (DPLM) to establish a biochemistry fellowship program in Calgary. However, the proposal was not funded, due to lack of resources. In 2012, Calgary Laboratory Services (CLS) and DPLM at the University of Calgary were able to obtain stable ongoing funding for a 2 year Clinical Biochemistry Fellowship Program in Calgary Alberta with the plan to fund one new fellowship position per year on an ongoing basis.

Top Row L-R: Apple Cebedo (Program Administrator), Drs. Jessica Boyd (Fellow, PDY-2) and Dennis Orton (Fellow, PDY-1), Isolde Seiden Long (Program Director), Hossein Sadrzadeh (Program Co-Director) Middle Row L-R: Sharon Lengsfeld (Chemistry Manager), Drs. Lyle Redman (POCT), Richard Krause (Chemistry), Lawrence de Koning (Paediatrics), Alex Chin (Immuno- and Special Chemistry) Bottom Row L-R: Vivian Piotrowski, Donna Duce (Chemistry Supervisors), Drs. Christopher Naugler (General Pathologist, Director of General Pathology Residency Program), Amid Abdullah (General Pathologist, Rural Labs) and Ethan Flynn (General Pathologist) In Absentia: Drs. Leland Baskin (Medical Director), James R Wright Jr. (Department Chair)


I arrived in Alberta in July 2012 and was appointed as Program Director by the chairman of the DPLM and this nomination was supported by the Fellowships Committee at DPLM. I was charged with the monumental task of establishing an accredited training program in Clinical Biochemistry where none had existed previously. While I had my own vision for setting up a training program, one of my fi rst thoughts was that I should speak with people who had started programs in Canada to gain their perspectives on training. However, when I started making inquiries about the history of training programs in Canada, I was surprised to discover that nobody had opened a new training program for more than 30 years and that all the accreditation standards currently employed by CACB had yet to be applied to a program that was starting from the ground up. While this news made the work quite challenging, it was also very exciting because it put our program in the unique position of being able to design the whole curriculum and program infrastructure using the excellent documentation that had been developed in recent years by the CACB and by ComACC in the USA. I would like to thank my fellow program directors Drs. Khosrow Adeli and Stephen Hill for their support and insightful discussions over the early months of establishing the program. I would also like to thank Dr. James R. Wright Jr., the Chair of DPLM, Dr. Leland Baskin, our Medical Director and Dr. Christopher Naugler, the program Director for the General Pathology residency program for their support and encouragement throughout the starting year of the program. I was also fortunate to be joined in Dec 2012 by Dr. Hossein Sadrzadeh, our new Clinical Section Chief, who had directed and co-directed several training programs in the USA and was a former member of ComACC. He has been highly supportive of the fellowship program, providing ongoing mentorship and has very recently joined me as program co-director in August 2014.

The Calgary Biochemistry Training Program is currently operated as a partnership between the Department of Pathology and Laboratory Medicine (DPLM) at the University of Calgary and Calgary Laboratory Services (CLS). Through our co-sponsorship with Calgary Laboratory Services, we are able to offer an innovative and dynamic training environment including opportunities to train in both hospital and community settings. This is a Full-time, 2 year Clinical Biochemistry Fellowship program consisting of Clinical and Analytical Biochemistry training objectives delivered through a combination of didactic, mentor-led, and self-directed learning meeting curriculum requirements for both Canadian Academy of Clinical Biochemistry (CACB) and American Board of Clinical Chemistry (ABCC) specialty certifi cation in Clinical Biochemistry. We admit one new fellow per year and have two fellows in training at any given time. We had our fi rst accreditation visit by CACB in May of 2013 and were granted a 2 year provisional accreditation as we had not yet admitted our fi rst trainee at that point! Our program admitted our very fi rst fellow Dr. Jessica Boyd, in July of 2013 and we have now admitted our second fellow Dr. Dennis Orton in July of 2014. Our next accreditation visit by CACB will be in May of

2015 and we’re looking forward to having them come to visit our site and speak with our fi rst fellows before they graduate.

Training primarily takes place in the core lab facility at the Calgary Laboratory Services Diagnostic and Scientifi c Center located near the University of Calgary. Our core lab facility receives 23,000 clinical specimens daily and performs a comprehensive menu of outpatient general chemistry tests, special chemistry testing and toxicology testing on a wide diversity of chemistry platforms. Fellows also spend time training at Foothills Medical Centre, which is a regional tertiary care facility with the largest emergency care service in Southern Alberta. It is home to a wide diversity of medical subspecialties and is attached to the Cumming Medical School at the University of Calgary. Our fellows complete their paediatric rotation at Alberta Children's Hospital that is also a Southern Alberta referral center. Additionally, Calgary Laboratory Services operate 12 community/rural laboratories in the Calgary region thus providing extensive exposure to different instrument platforms and management training opportunities. While the program is primarily operated by DPLM/CLS, other lab locations in Alberta including University of Alberta Hospital, Red Deer, and the Alberta Center for Toxicology all offer electives for Biochemistry Fellows as well. I would like to acknowledge our clinical biochemist colleagues in other laboratories for their support of our program. Our fi rst fellow, Dr. Boyd had the opportunity to do an elective rotation coordinated by Dr. Kareena Schnabl in Edmonton and spend some time in toxicology and inborn errors of metabolism and she will be doing another elective with Dr. David Kinniburgh at the Alberta Center for Toxicology.

We are fortunate to have a large Medical Scientifi c teaching faculty of 6 Clinical Biochemists in Calgary (Drs. Isolde Seiden Long, Hossein Sadrzadeh, Richard Krause, Alex Chin, Lawrence de Koning, and Lyle Redman) and several General Pathologists (Drs. Leland Baskin, Ethan Flynn, Amid Abdullah and Christopher Naugler) . We currently have active research programs in mass spectrometry and analytical method development, laboratory automation and epidemiology. A unique strength of our program is our ready access to laboratory informatics. With a catchment population of close to 1.4 million people on a common laboratory system and 23 million reported tests per year, our training environment offers tremendous opportunities for research.

Detailed information about the program and application instructions for interested fellows can all be obtained from our departmental website: http://www.pathology.ucalgary.ca/content/clinical-fellowship-programs

Dr. Isolde Seiden Long, PhD, DCC, FCACB, DABCCProgram Director


My Time on CouncilMy time on CSCC Council was

quite the experience! It all started 6 years ago when Sherry Perkins burst into my offi ce, actually more of a small explosion, and announced I was to be the next Treasurer. My fi rst thought was…the next WHAT? Although I can count with the best of them, I had no aspirations to become the treasurer of anything. Actually hadn’t thought of joining CSCC Council at that point. I was already on OSCC council and that was enough for me. So after at least three refusals, some more convincing by Sherry, and a chat with Dave Kinniburgh (Treasurer at the time), I accepted. Although I suspect Dave would have said just about anything to fi nd a replacement after his 8 years as treasurer. Was the best decision I ever made!

I had no idea what to expect when I arrived at the council meeting. I was pleasantly surprised to fi nd Ray Lepage as my president. My fi rst impression was one of a reserved, proper gentleman president. Half way through my fi rst meeting I found out that Ray had a hilariously dry wit, and was one of the funniest people I knew. He kept the whole Council gang engaged and provided an enjoyable environment. And Liz, Council’s “Mom”, made sure we got all the right things done.

In terms of “Treasuring”, I was as lucky as you could get! Dave left the fi nances in an exemplary state, and the Society has had the benefi t of a very successful journal. We have consolidated the investments with TD Waterhouse and as a society decided on a low and no risk strategy for moving the fi nances forward...phew! Because of the fi nancial success of the Society, we have been able to increase the offerings to the members including the Roundtables, improved website and web-based PD program.

The two most memorable events during my stay on Council did not occur at council meetings. Now the meetings can be looong, but don’t get me wrong, they are also quite entertaining and enlightening. But the opportunities that arise as a Council member can be even

better. One of those “perks” is the Council dinner after a long day of debating the issues affecting our Society. Liz always fi nds a nice quiet dinner spot for all to refl ect on the day of intense intellectual discussion. The post-Council meeting of 2011 in Vancouver was no different…or so we thought. Liz booked us a nice spot a short walk away from the hotel. As usual, a few of us decided to go for a pre-dinner pint and watch the Canucks beat the Bruins in game two of the Stanley Cup fi nals. So off we went to hunt for a proper pub. With no real direction in mind we headed toward Liz’s chosen dinner reservation. We hit one pub, all full. Another, also full, a third…FULL! Are you kidding me? We needed a pint, bad! What were we to do? Keep walking I guess. But as we round the corner, what’s this? Why is the road closed (Figure 1)? Construction?

Nope! As we round the next corner, just about everyone from the lower mainland had converged on Robson St (Figure 2). It was wall-to-wall people, some sober and cheering, some less than sober, walking a bit off-kilter, others, somewhere in-between. One rather inebriated fellow walked directly into a tree, excused himself, backed up, very politely apologized to the tree and continued on his drunken’ wander. All while carrying a 6-pack! We never did fi nd that pub, and just ended up at the restaurant. Dinner was great (as usual). The walk back though was something else! Vancouver won that game, and every bar emptied their drunken’ contents onto the streets. Everyone cheering, random hugs for all as we made our way back to the hotel.

I also had the opportunity to represent the CSCC at the 12th Iranian Congress of Biochemistry & 4th International Congress of Biochemistry and Molecular Biology in Mashhad, Iran. It all started with a request from the Iranian Congress to publish their abstracts in Clinical Biochemistry. We agreed and they offered to have a member of the CSCC Council attend their meeting and give a lecture. The president declined, as did the Secretary. I thought about it for about 1 minute and agreed, the chance to visit the Middle East, you bet! And the saga began... I applied for a visa in early July, no worries, lots of time the congress isn’t until September. Little did I know that things move slowly in the Iranian heat. The planning continued, fl ights were booked (well sort of) and I honed my lecture. It’s now the week before the Congress, I still don’t have my visa and I’m getting a bit concerned. My ticket, however, did arrive by email. It’s now the Friday before the Congress, my fl ight is booked to leave this Sunday and no visa yet! I’ve progressed to

Vancouver (Figure 1)

Vancouver (Figure 2)


a near panic. As I’m furiously typing an email to the organizers, the confi rmation of my visa arrives in my inbox…phew, I’m good to go, or so I thought. Turns out I need to visit the Iranian embassy to collect my visa, but its closed on the weekend and Monday is a holiday! After some serious fl ight juggling, 3 trips to the embassy and a quick conference call with the Iranian Ambassador (really nice guy by the way) I get my visa and by Tuesday night I’m off to Frankfurt. I arrive in Frankfurt and there is an email waiting for me. They forgot to mention that after the 11h layover and a 5½ h fl ight to Tehran International Airport, I need to cab to the domestic airport, 45 min away…Great!

So to recap, after a 7h fl ight to Frankfurt, 11h of exhaustively exploring Frankfurt Airport, test driving every possible sleep-inducing seat in the airport (and not sleeping a wink), a 5½h fl ight to Tehran, I would have to navigate customs (really easy on the way in BTW), exchange my US cash for Iranian Rials (Rial cash is the only currency accepted), fi nd a cab and explain to the driver (who spoke no English) I needed to go to the domestic airport, all at 2:30am local time! Things went pretty well considering a sleep-deprived mental haze. I did discover that fl apping your arms like an airplane really is an international sign for airport and lining up in Iran is not required. If you think you need to queue-up, no need, just join the small crowd of people around whatever it is you

thought you were lining up for and hope for the best. In the end, I made it to Mashhad, gave my lecture, met some amazing people, had lots of discussion, and some great food too. My talk was on autoimmune testing (Autoantibody-based Neurological Disorders: Clinical suspicion to laboratory diagnosis) and the lecture hall was packed. I had lots of questions, many about how they could fi nd a Post-Doc or residency placement in Canada. The Congress, held at the Mashhad University of Medical Sciences was a perfect mix of basic science and clinical medicine. Sadly since my visa was delayed I was only able to attend one day of the Congress. I did have a chance to visit some of the city as well as the 2nd largest Mosque in the world, simply stunning. I would encourage anyone to visit Iran, the people were wonderful as were the sights (Figure 3).

All in all, my time on Council is one that I will never forget. I made some new friends and colleagues from across the country, made a positive mark on our society (I hope) and now truly understand how important the CSCC is to all of us. I encourage everyone to participate in Council; I guarantee you will come out the other side more enlightened and better for the experience. Thanks to all that served on Council for putting up with me, and a special thanks to Liz (and Events Management) for holding us all together. Hope I’ll be back on Council some day.

Dr. Ron Booth

Photos from Iran


2014 CSCC Travelling LectureshipSponsored by

Dr. Mario PlebaniFull Professor, Clinical Chemistry and Clinical Molecular Biology, University of Padova, School of MedicineDirectror, Post-graduate Course in Clinical Biochemistry, University of PadovaChief, Department of Laboratory Medicine, University Hospital of PadovaChief, Centre of Biomedical Research, Veneto RegionScientifi c Co-ordinator, Regional Laboratory Anti-doping, Laboratory Medicine, University Hospital of Padova

Quality Management and its Impact on Patient Safety: First do not harm

The International Standard for medical laboratories accreditation (ISO 15189: 2013) requires that “the laboratory establishes, documents, implement and maintains a quality management system”. The main goals of this system is to meet the needs and requirements of the users and, fi rst and foremost, to avoid errors in the total testing process (TTP), namely errors that could cause harm to the patients. The application of the “process approach” should allow clinical laboratories to evaluate the entire testing process and set quality specifi cations for each step in order to identify weakness in policies and procedures thus providing opportunities for quality improvement through the formulation and prioritisation of corrective actions. The session will review the state-of-the-art regarding quality and errors in laboratory medicine as well as the right approach to developing and implementing a quality management system in clinical laboratories.

At the conclusion of this session, participants will be able to:1. understand the link between quality in laboratory testing and patient safety2. identify the right meaning and implementation of a quality management system in

laboratory medicine3. discuss approaches, challenges and opportunities for improving quality in laboratory

medicine

Harmonization in Laboratory Medicine as a Global Picture: The request, the sample, the measurement, and the report

The acute lack of interchangeable laboratory results and consensus in current practice among clinical laboratories has recently underpinned greater attention to standardization and harmonization projects. The main drivers for standardization and harmonization projects are fi rst and foremost patient safety, but also the increasing trends towards consolidation and networking of clinical laboratories, accreditation programs, and clinical governance. Although the focus is mainly on the standardization of measurement procedures, the scope of harmonization goes beyond method and analytical results: it includes all other aspects of laboratory testing, including terminology and units, report formats, reference intervals and decision limits, as well as test profi les and criteria for the interpretation of results.

At the conclusion of this session, participants will be able to:1) identify differences between harmonization and standardization2) identify the focus on harmonization projects in pre-, intra- and post-analytical phases3) update knowledge on the roadmap for harmonization in laboratory medicine.

LECTURESHIP SCHEDULE

Tuesday September 23, 2014 VancouverFriday September 26, 2014 CalgaryMonday September 29, 2014 WinnipegWednesday October 1, 2014 TorontoFriday October 3, 2014 Quebec City


Maria PasicM a r i a i s t h e

Clinical Chemist at St. Joseph’s Health Centre in Toronto, where she has worked for 2 years. She completed her PhD at McMaster University and her Postdoctoral training in Clinical Chemistry at the University of Toronto. She also did an additional one-year fellowship in Molecular Diagnostics at the University Health Network. For her past research activities, Maria has received a Young Investigator Award from the International Society of Thrombosis and Haemostasis, and the George Grannis Award from the American Association for Clinical Chemistry. Also an Assistant Professor at the University of Toronto, Maria is one of the course coordinators for “Next Generation Genomics in Clinical Medicine”. Her main research interests are in personalized medicine and new biomarker discovery. Maria’s other full-time job is being mom to 2-year old Anastasia and 9-month old Katarina. Her favorite activities with her children are music and sports. Maria has been playing tennis since she was 4 years old, and has already introduced Anastasia to her favorite sport with the help of grandpa Eleftherios (Diamandis). Katarina is expected to follow, so they can make a doubles team!

Jennifer SheaI am currently

t h e D i v i s i o n Head of Clinical C h e m i s t r y a t the Sa in t John Regional Hospital i n Sa in t John , New Brunswick. I completed my u n d e r g r a d u a t e degree at Mount Allison University in Sackville, NB followed by a PhD in Human Genetics at Memorial University of Newfoundland. During my PhD, I became acquainted with the career of clinical chemistry through Dr. Ed Randell, who sat on my PhD supervisory committee. I largely credit him for developing my interest in this fi eld and providing support that ultimately helped me get into a training program. I completed my Clinical Chemistry training at the University of Toronto under the guidance of many wonderful and brilliant biochemists. Having the opportunity to rotate through a number of large academic hospitals was an excellent learning experience and I continue to draw on those experiences as I navigate the waters in my new career. I also met some great friends in the program that helped me deal with the daily stressors of being a Clinical Chemistry trainee – without them, I’m not sure that I would have survived the two year training program!

As a Clinical Chemist in Saint John, I am kept very busy with general chemistry service, teaching as part of a new local medical school that is affiliated with Dalhousie University, and most recently, in the fi eld of forensic toxicology under the supervision of Dr. Albert Fraser. As both myself and my husband grew up in the Maritimes, we are very happy to be back working in NB close to our family and friends.

New Clinical Biochemist FellowsMathew Estey

One fa te fu l even ing in the final year of my graduate studies at the University of Toronto, I arrived at my girlfriend’s lab to pick her up for dinner. Not surprisingly, she was running late (this was not an uncommon occurrence) and needed more time to fi nish her experiments. At the time, I was struggling with fi guring out what to do after graduation – I had considered a research postdoc, medical school and entering the workforce, but nothing seemed to be the right fi t. I decided to go for a stroll down the hall, where I came across a poster for the Clinical Chemistry Postdoctoral Fellowship. It described a profession that I had never heard of, but sounded exactly like what I was looking for.

I started the program the following year and was not disappointed. During my Fellowship, I wrote two papers on metal toxicity from prosthetic hip implants, an area in which I maintain an active interest. I was the fi rst author of the CALIPER transference study, a Canada-wide initiative to determine pediatric reference intervals for many laboratory tests. I also had the pleasure of teaching fi rst year medical students the fundamentals of diagnostic biochemical markers.

After completing the training program in June 2013, I moved to Edmonton, Alberta to work as a Clinical Chemist at DynaLIFE Diagnostics. I am also currently a Clinical Assistant Professor at the University of Alberta, where I teach undergraduate students, medical students, and medical residents. My current interests include hemoglobinopathies, endocrinology, cobalt/chromium toxicity, and celiac disease.

In May of this year I married the love of my life, the same woman who inadvertently helped me solve my career dilemma several years ago by being for late dinner. We spent our honeymoon in Hong Kong and Maldives right after the CSCC conference in PEI, and are now living happily together in

Edmonton. In my spare time I enjoy cooking (and eating), biking, skiing, playing board games, and watching hockey.

Vilte BarakauskasI fi rst learned of

clinical chemistry as an undergraduate b i o c h e m i s t r y student. It was Dr. Christine Collier who introduced me to the clinical lab, database research and test utilization.


Her mentorship and encouragement saw me attend my fi rst CSCC annual meeting as well! At this time two things struck me and have stayed with me since: the impact of the clinical laboratory on patients and healthcare; and, the collegiality and comradery of the clinical chemistry community.

The appeal of applying biochemistry in a clinical context led me to graduate studies in Neuroscience at UBC where I worked with brain issue and validated ELISA and mass spectrometry-based protein assays. Under the mentorship of a wonderful clinician-scientist, my graduate work included interacting with a multidisciplinary team of basic researchers and clinicians. I also sought to develop experience in education through coursework, working at the UBC teaching and learning center and developing a neuroimaging rotation for psychiatry residents. My enthusiasm for clinical applications of biochemistry and mass spectrometry, method development, validation and quality control, collaborative clinical research, process optimization, and education was thus solidifi ed during graduate school, and it was very exciting to realize that these components comprise the work of a clinical chemist.

Fortunately I was able to pursue these interests in the Clinical Chemistry fellowship program at the University of Utah/ARUP Laboratories. Under the directorship of Drs. Elizabeth Frank and David Grenache this was an exceptionally positive training experience, with strong clinical, analytical and leadership components, and providing exposure to diverse aspects of laboratory medicine both in hospital and reference lab settings. I certifi ed with the ABCC in 2013 and am pleased to be able to join the CACB fellowship this year.

I am excited to be back in the Canadian clinical chemistry community, which started me off on this career path many years ago! I joined DynaLIFEDx as a clinical chemist in May of 2013, and the Department of Laboratory Medicine at UofA last fall. I remain interested in clinical applications of mass spectrometry, test utilization and process optimization, toxicology, endocrinology, esoteric testing and teaching/education. I have expanded my experience in celiac disease, alpha-1-antitrypsin defi ciency, hemoglobinopathy investigation and laboratory services delivery in northern Canada. Together with my husband, I am enjoying exploring the new city we live in - taking in the amazing river valley trail system, abundant festivals and long summer days of Edmonton!

The XIIIth International Congress of Pediatric Laboratory Medicine (ICPLM)

The XIIIth International Congress of Pediatric Laboratory Medicine (ICPLM) took place in Istanbul, Turkey, June 20-22nd,2014., and drew more than 200 registered participants from over 40 different countries. The Congress, a satellite meeting that preceded the IFCC WorldLab, took place at the same venue. Four Plenary Lectures and twelve Symposia offered more than 30 speakers, and presentations were well acclaimed. The symposia on nutrition, cancer, reference intervals, and panel discussion included speakers from McMaster University and Hospital for Sick Children. Our own CSCC members in attendance as delegates, speakers and/or organizers included: Andrew Don-Wauchope, Joseph Macri, Li Wang, Khosrow Adeli, Vijaylaxmi Grey (chair of the congress). Additionally, more than 50 scientifi c posters were exhibited across the spectrum of pediatric laboratory medicine. Li Wang (BC Children’s hospital) was one of two poster award winners. Jakob Zierk of Germany was the second winner.

Under the dynamic leadership of the IFCC Task Force of Pediatric Laboratory Medicine, Chair Vijay Grey (Canada), Past Chair Klaus Kohse (Germany), Vice-Chair Michael Metz (Australia), and members Tim Lang (UK), Patti Jones (USA), Sharon Geaghan (USA), the ICPLM raised enough monies from both sponsorship and registration fees, to make this a fi nancially successful Congress. The CSCC was generous not only in its sponsorship support but also the publication of the proceedings of the congress in Clinical Biochemistry. We thank Pete Kavsak and the editorial staff of Clinical Biochemistry for their efforts. Other national societies also contributed monies towards speakers.

If you weren’t fortunate enough to attend, the short papers proffered are to be found in a special edition of Clinical Biochemistry (Volume 47, Issue 9, Pages 691-864 (June 2014) http://www.sciencedirect.com/science/journal/00099120) devoted to the XIIIth International Congress of Paediatric Laboratory Medicine, thanks to the work of Guest Editors, Vijaylaxmi Grey and Klaus P. Kohse, Tim Lang and Michael Metz.

The XIVth ICPLM will be held in Durban, South Africa, October 2017. Do plan to be there, the preparation has already begun. Pediatric Laboratory Medicine is more than about little adults!

Thanks to Elizabeth Hooper and the CSCC offi ce for all the postings about the XIIIth ICPLM 2014 meeting.

Dr. Vijaylaxmi Grey, Chair, ICPLM 2014

Application Deadline for Oral Exams• Fellowship Applications under Category 3 or 4• Trainees Re-Sitting the Oral Exam

Applicants who wish to apply for Fellowship who are applying under category 3 or 4 and trainees who are re-sitting the oral exam must apply by November 30, 2014. Applications received after November 30, 2014 if eligible, would take the oral exam in June 2016.


The Archives Corner

This year marks the 50 th anniversary of the incorporation of CSCC, an important step for the Society because of the decision by the membership at its 1961 Annual General Meeting to begin the process of certifi cation of clinical chemists within Canada. Legal advice to Council stated clearly that incorporation would protect Offi cers of Council and any other member holding a position on behalf of the Society from being sued

as individuals against lawsuits and the like, and therefore Council agreed it would be prudent to have incorporation precede the introduction of certifi cation. A notice of application to incorporate had been sent to members by Dr. David B. Tonks, Secretary of CSCC, and I think it would be interesting to include here the full text of the notice:

“Notice is hereby given that the members of the Society at the General Meeting called for the 16th day of June, 1964, will be asked to consider and, if approved, to pass with or without variation a resolution authorizing the Council of the Society to make application to the Secretary of State of Canada for Letters Patent of Incorporation and to enter into a Memorandum of Agreement, both in the form annexed to this notice, and further authorizing the proper offi cers of the Society to enter into an agreement with the corporation thus formed providing for the transfer of the assets and undertaking of the Society to the Corporation, the issuing of membership in the Corporation to members of the Society, and such other matters as may be necessary to permit the corporation to carry on the business of the Society.

“Dated this 8th day of May, 1964. Signed D.B. Tonks, Ph.D., FCIC Secretary”

Quoting from the Minutes of the 1964 Annual General Meeting, “Dr. Tonks explained that the process of incorporation necessitated some changes to be made in the Constitution and By-Laws and stated that notice had been given of these proposed changes, which would be considered subsequently at this meeting. “ Then Dr. Sanford H. Jackson, as representative of the Committee on Incorporation and Constitution, discussed point by point the necessary revisions, the motion on the resolution was put to a vote, and carried unanimously. One small but important change contained in the 13 amendments to the 1962 Constitution was the change of the Society’s name from “Canadian Society for Clinical Chemistry” to the name still used today, “Canadian Society of Clinical Chemists”.

The Committee on Certifi cation then reported on the total number of applications for certifi cation reviewed by the Committee (58), with 40 approved for grandfathering, 16 rejected and 2 held

over. [It should be noted that application for grandfathering was briefl y re-opened a few years later during the presidency of Dr. Samuel Levy (1970-71)]. Formal application for certifi cation by examination was advertised to the membership and came into force in the late 1960’s and, as many readers will recall, the fi rst CSCC member certifi ed by examination was Dr. J. Gilbert Hill of Toronto; although amply qualifi ed to have been grandfathered and thus to receive certifi cation without examination, Dr. Hill stated he “wanted to keep the process honest”.

As noted above, this was the fi rst step on what proved to be a longer road than anyone could have anticipated in the 1950’s, culminating in 1986 in the formation of the Canadian Academy of Clinical Biochemistry, the year of CSCC’s thirtieth anniversary. There is a thick ledger in the archives at CSCC’s Head Offi ce in Kingston where one can see the Letters Patent and the signatures of the original signatories to the act of incorporation.

Dr. Arlene Crowe, Member, Archives Committee

Val DiasDr. Valerian (Val) Dias celebrated his retirement after 8 years of service with Calgary Lab Services (CLS) on June 26, 2014. Being the social butterfl y that he is, about 50 guests attended his retirement tea party, including his wife, Gisele. Dr. Leland Baskin, VP Medical Operations, and Dr. Hossein Sadrzadeh, Clinical Biochemistry Section Chief, shared testimonies of Val’s great contributions to CLS. A slide show of wonderful memories of Val’s career was showcased and enjoyed by his fellow clinical chemists, medical lab technologists, medical/scientifi c staff. The Clinical Biochemistry Section is proud to have worked with Val. He has made excellent contributions and accomplishments in the fi eld of Clinical Biochemistry, as well as to the lives of the patients and colleagues he has touched. On behalf of Calgary Lab Services, please join us to wish Val a happy retirement and to enjoy all his ice fi shing adventures!

Clinical BiochemistryThe IFCC booth at the Istanbul Congress in June 2014 featured Clinical Biochemistry.


Call for Nominations for CouncilAppel de candidatures pour le Conseil d’administrationCSCC Council / Conseil de la SCCC

Position / Poste Term of Offi ce/Terme du mandat

President-Elect / Président élu 2015-2017Secretary / Secrétaire 2015-2018Head, Publications Division / Chef, division des publications 2015-2018Councillor / Conseiller – 2 positions open(2 postes vacantes) 2015-2017

Nominations must be signed by three (3) members who are eligible to nominate, one (1) of whom shall act as the proposer, and shall be accompanied by the written consent of the nominee./ Les avis de candidature doivent être signés par trois (3) membres qualifi és (avec droit de vote) dont un (1) devra agir comme proposeur. Les avis de candidature doivent également être accompagnés du consentement écrit des candidats.

Chair, Nominations Committee / le président du Comité des nominations / Dr. Edward Randell

Call for Applications for 2015 GrantsMembers of CSCC are invited to apply for the following grants:

• CSCC Educational Activities and Professional Development Grant - Sponsored by CSCC

• CSCC Grant for Leadership and/or Administration - Sponsored by Abbott Laboratories

Terms of Reference and application forms are available on the CSCC website under About Us > Awards and Grants

Call for Nominations for 2014 Awards / Appel de candidatures pour les prix annuelsCSCC 2015 Awards / Prix de la SCCC 2015

Members of CSCC are invited to nominate a member who they feel is deserving of these awards./ Les membres de la SCCC sont invites à faire parvenir le nom d’un candidat méritoire.

• Award for Outstanding Contributions to Clinical Chemistry / Prix pour Contribution exceptionnelle à la chimie clinique

Sponsored by / Commandité par Siemens Healthcare Diagnostics

• Research Excellence Award / Prix d’Excellence en Recherche Sponsored by / Commandité par Ortho-Clinical Diagnostics

• Education Excellence Award / Prix d’Excellence en Éducation Sponsored by/Commandité par Beckman Coulter Inc.

NEW......• CSCC Award for Innovation in Laboratory Medicine - Sponsored by

Roche Diagnostics

CACB 2015 Award / Prix de l’ACBC 2015

• Award for Outstanding Contributions to the Profession of Clinical Biochemistry / Prix pour Contribution exceptionnelle à la profession de biochimiste clinique

The Canadian Academy of Clinical Biochemistry would like to honour a Fellow of the Academy for outstanding contributions that had advanced the standards and recognition of Clinical Biochemistry as a health care profession. / L’Académie canadienne de biochimie clinique désire honorer un Fellow de l’Académie pour sa contribution à l’amélioration des standards de pratique et à la reconnaissance du biochimiste clinique comme Professionnel de la santé.

Members of the Academy are invited to nominate a Fellow who they feel is deserving of this award. / Les membres de l’Académie sont invités à faire parvenir le nom d’un candidat méritoire.

Nominations must include/ Les dossiers de candidature doivent inclure:

• Letter of nomination with supporting information indicating why the nominee is deserving of the award / Une lettre de mise en candidature incluant toute information décrivant les raisons justifi ant la demande

• CV of nominee / Le Curriculum vitae du candidat

• Letter from the seconder of the award nomination / Une lettre d’appui à la candidature

Nominations must be received by November 30, 2014 / Les dossiers de candidature doivent être reçus avant le

30 novembre 2014

Sent to/Envoyer à : offi [email protected]

Past award winners may be viewed on the CSCC website

www.cscc.ca


CSCC Award for Innovationin Laboratory Medicine

Sponsored by Roche Diagnostics

Terms of Reference

1. The Award shall be presented to a Clinical Laboratory in Canada that has distinguished itself by outstanding accomplishment through innovation in the fi eld of Clinical Chemistry, or Pathology and Laboratory Medicine for projects where a CSCC member was directly involved. This award is intended to encourage and recognize excellence in Clinical Laboratory Services especially in the role of improving the quality of health care, improving patient outcomes, and promoting a positive public image to clinical laboratories and laboratory professionals.

2. Eligible organizations for this award include:2.1. Private, Academic and Government Clinical Laboratories and Laboratory divisions.2.2. Rural and Regional Clinical Laboratories and Clinical Laboratory Departments.

3. Laboratories demonstrating outstanding accomplishments in one or more of the following areas completed within the last two calendar years are eligible for consideration:3.1. Innovation in strategic planning and implementation of laboratory services based on best practices.3.2. Innovation in development of new laboratory programs (e.g. new tests, facilities, and changes in practice).3.3. Innovation in teaching and education.3.4. Promotion of a positive public image for laboratory medicine.

4. Nominations for this award will be received from members of the CSCC to the Awards Committee through the Head Offi ce of the Society. Nominations for this award will include:4.1. A completed application form including a summary of the accomplishment(s) of the nominated organization with supporting documentation.4.2. A letter of support from a CSCC member involved in the project for which the organization is being nominated.4.3. A letter of support from the nominee’s organization administrative team (Signed by a Department Director, VP, or CEO).

5. The CSCC supporting member and a representative from the administration of hospital or institution represented in the project will be invited to accept the award (plaque and display item) at the CSCC Annual Meeting banquet. The award will be presented by a representative from Roche Diagnostics. The award will cover airfare, accommodations and expenses for 2 nights for both recipients, as per the CSCC Travel Guidelines. Photographs and a brief summary of the award will be provided to the hospital or institution for their publication.

Terms of Reference and the application form are found on the CSCC Website under About Us / Awards and Grants


The CSCC News is published bimonthly by the Canadian Society of Clinical Chemists and distributed to the members by the Society. Letters to the Editor must be signed and should not exceed 200 words in length. Chairs of Committees and Local Sections are requested to submit announcements and reports of activities.

Deadline for Submissions:

December 31 January issueFebruary 28 March issueApril 30 May issueJune 30 July issueAugust 30 September issueOctober 30 November issue

Notices from members seeking employment may be inserted without charge, and box-number replies may be arranged. Notices from institutions will be invoiced at $150 and include a notice on the website on the Job Opportunities page.

Views and reports appearing in CSCC News do not necessarily have the endorsement of the Society. Address general communications to the Editor care of the CSCC Head Offi ce.

Editor in Chief: Dr. Mary-Ann Kallai-Sanfaçon

Associate Editors: Dr. Cheryl Tomalty, Dr. Kareena Schnabl

Publication Offi ce:

CSCC News

C/o CSCC Head Offi ce4 Cataraqui St., Suite 310, Kingston ON K7K 1Z7Tel: 613-531-8899 • Fax: 613-531-0626offi [email protected]

CALENDAR OF EVENTS

2014-2015 Executive & Council of the CSCC

President David Kinniburgh 2013-2015President-Elect Andrew Lyon 2013-2015Secretary Stephen Hill 2012-2015Treasurer Ivan Blasutig 2014-2017Councillors Isolde Seiden Long 2014-2016 Vathany Kulasingam 2013-2015 AbdulRazaq A.H. Sokoro 2013-2015

Division Heads:

Education & Scientifi c Affairs Allison Venner 2013-2016Professional Affairs Julie Shaw 2013-2016Publications Curtis Oleschuk 2012-2015Executive Director Elizabeth Hooper

2014-2015 Board of Directors of the CACB

Chair Sheila Boss 2014-2017Secretary Lianna Kyriakopoulou 2012-2015Chair, Accreditation Annu Khajuria 2012-2015Chair, Certifi cation Mary-Ann Kallai-Sanfaçon 2013-2016Chair, Credentials Cheryl Tomalty 2014-2017Chair, Maintenance of Competence Paul Yip 2013-2016Liaison, Nominations & Awards Ihssan Bouhtiauy 2013-2016Committees

If you would like to announce your meeting, please send at least 3 months in advance to offi [email protected]

October 8-10, 2014La matrice décryptée35th Annual ConferenceSociété Québécoise de biologie CliniqueHôtel Universel de Rivière-du-Loup, Québec

October 24-25, 2014“Biomarkers in Neuropsychiatric Disorders”IFCC-Siemens Specialty ConferenceOmni King Edward Hotel, Toronto ON

June 20-24, 20152015 CSCC-CAP Joint Annual Conference (Canadian Laboratory Medicine Congress (CLMC)Clinical Biochemistry on the MoveWestin Montréal HotelMontréal Quebechttp://www.clmc.ca/2015/

June 21-25, 2015Euromedlab Paris 201521st IFCC-EFLM Congress of Clinical Chemistry and Laboratory MedicinePalais des congrès, Parishttp://www.paris2015.org/

July 26-30, 20152015 Annual Meeting & Clinical ExpoAACCAtlanta Georgia

October 11-15, 201514th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology 2015Rotterdam, the Netherlandshttp://iatdmct2015.org/

T H A N K S T O O U R C S C C N E W S S P O N S O R S !

Documents

CSCC NEWS September 2014